GFPT1 Gene Myasthenia congenital with tubular aggregates 1 Genetic Test
Test Name: GFPT1 Gene Myasthenia congenital with tubular aggregates 1 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GFPT1 Gene Myasthenia congenital with tubular aggregates 1.
Test Details: The GFPT1 gene is associated with a condition called Myasthenia Congenita with Tubular Aggregates 1 (MCTA1). This is a rare genetic disorder that affects the neuromuscular junction, leading to muscle weakness and fatigue. NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze a person’s DNA to identify genetic variations or mutations that may be associated with certain diseases or conditions. In the case of MCTA1, NGS genetic testing can be used to identify mutations in the GFPT1 gene that are responsible for causing the condition. By performing this genetic test, healthcare professionals can provide an accurate diagnosis for individuals suspected of having MCTA1. This information can help guide treatment decisions and provide important information for genetic counseling and family planning.
Note: Genetic testing for MCTA1 is typically performed by healthcare professionals with expertise in genetics, such as genetic counselors or clinical geneticists. If you suspect that you or someone you know may have MCTA1, it is recommended to consult with a healthcare professional who can guide you through the testing process.
Test Name | GFPT1 Gene Myasthenia congenital with tubular aggregates 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GFPT1 Gene Myasthenia congenital with tubular aggregates 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GFPT1 Gene Myasthenia congenital with tubular aggregates 1 |
Test Details |
The GFPT1 gene is associated with a condition called Myasthenia Congenita with Tubular Aggregates 1 (MCTA1). This is a rare genetic disorder that affects the neuromuscular junction, leading to muscle weakness and fatigue. NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze a person’s DNA to identify genetic variations or mutations that may be associated with certain diseases or conditions. In the case of MCTA1, NGS genetic testing can be used to identify mutations in the GFPT1 gene that are responsible for causing the condition. By performing this genetic test, healthcare professionals can provide an accurate diagnosis for individuals suspected of having MCTA1. This information can help guide treatment decisions and provide important information for genetic counseling and family planning. It’s important to note that genetic testing for MCTA1 is typically performed by healthcare professionals with expertise in genetics, such as genetic counselors or clinical geneticists. If you suspect that you or someone you know may have MCTA1, it is recommended to consult with a healthcare professional who can guide you through the testing process. |